A biotechnology company, pursuing commercial opportunities in: out-licensing its non-coding patents globally; expanding genetic service-testing business in the Asia-Pacific Region; & supporting research projects in which it is already involved.


Updates from The Motley Fool

Latest updates on Genetic Technologies from Fool.com.


Stock Performance

GENE vs. S&P 500 | 2 Year Performance
View Interactive GENE Charts
Sponsored by

Key Data Points

Primary metrics and data points about Genetic Technologies.
Current Price: $2.03
Prev Close: $2.05
Open: $2.04
Bid: $2.00
Ask: $2.07
Day's Range: $2.02 - $2.07
52wk Range: $1.62 - $4.27
Volume: 46,382
Avg Vol 54,566
Market Cap: $23.21M
P/E (ttm): -0.77
EPS (ttm): $0.00
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Genetic Technologies.
CAPS Rating 1 out of 5
 
30 Outperform
61 Underperform
CAPS All Stars
 
1 Outperform
33 Underperform

How do you think Genetic Technologies will perform against the market?



You pick for Genetic Technologies is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Alison Mew, CEO

0% Approve

Based on 0 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Genetic Technologies.

A biotechnology company, pursuing commercial opportunities in: out-licensing its non-coding patents globally; expanding genetic service-testing business in the Asia-Pacific Region; & supporting research projects in which it is already involved.

  • Exchange: NASDAQ
  • Sector: Services
  • Industry: Diversified Services